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1030 | Chem. Sci., 2014, 5, 1030–1040Simultaneous detection and quantiﬁcation of three
bacterial meningitis pathogens by SERS
Kirsten Gracie,a Elon Correa,b Samuel Mabbott,a Jennifer A. Dougan,a
Duncan Graham,a Royston Goodacre*b and Karen Faulds*a
Bacterial meningitis is well known for its rapid onset and high mortality rates, therefore rapid detection of
bacteria found in cerebral spinal ﬂuid (CSF) and subsequent eﬀective treatment is crucial. A new
quantitative assay for detection of three pathogens that result in bacterial meningitis using a combination
of lambda exonuclease (l-exonuclease) and surface enhanced Raman scattering (SERS) is reported. SERS
challenges current ﬂuorescent-based detection methods in terms of both sensitivity and more
importantly the detection of multiple components in a mixture, which is becoming increasingly more
desirable for clinical diagnostics. l-Exonuclease is a processive enzyme that digests one strand of double
stranded DNA bearing a terminal 50-phosphate group. The new assay format involves the simultaneous
hybridisation of two complementary DNA probes (one containing a SERS active dye) to a target
sequence followed by l-exonuclease digestion of double stranded DNA and SERS detection of the
digestion product. Three meningitis pathogens were successfully quantiﬁed in a multiplexed test with
calculated limits of detection in the pico-molar range, eliminating the need for time consuming culture
based methods that are currently used for analysis. Quantiﬁcation of each individual pathogen in a
mixture using SERS is complex, however, this is the ﬁrst report that this is possible using the unique
spectral features of the SERS signals combined with partial least squares (PLS) regression. This is a
powerful demonstration of the ability of this SERS assay to be used for analysis of clinically relevant
targets with signiﬁcant advantages over existing approaches and oﬀers the opportunity for future
deployment in healthcare applications.Introduction
The detection of DNA sequences correlating to specic disease
states has become vital in medical diagnostics. The majority of
current methods of DNA detection involve the polymerase chain
reaction (PCR) coupled with various uorescence-based tech-
niques.1,2 An alternative optical spectroscopy is surface
enhanced Raman scattering (SERS) which is fast becoming a
sensitive,3 highly molecularly specic technique with the ability
to detect multiple analytes simultaneously due to the charac-
teristic molecular ngerprint spectra obtained.4,5 As a result,
numerous assays have been developed that involve the direct
detection of DNA using SERS.6–11 The detection of many
diﬀerent disease states is possible but in order to demonstrate
the potential of using SERS for analysis of disease, we opted for
an infectious disease target since when the target is present, a
positive result and identication is possible.CHEM, Department of Pure and Applied
athedral Street, Glasgow, G1 1XL, UK.
stitute of Biotechnology, University of
r, M1 7ND, UKMeningitis is an inammation of the lining around the brain
and spinal cord. Most cases of meningitis are caused by viruses
such as herpes, mumps or measles.12–14 Unfortunately there are
no eﬀective therapies for most viruses that cause meningitis;
therefore treatment is aimed at limiting the eﬀects of the
symptoms. Meningitis and septicaemia caused by bacteria are
usually more serious compared to viral meningitis and require
urgent medical attention with appropriate antibiotic therapy.
Around 3400 people each year in the UK and Ireland are aﬀected
by bacterial meningitis, according to an investigation by the
Meningitis Research Foundation.15,16 Three of the most
common meningitis pathogens are Haemophilus inuenzae,
Streptococcus pneumoniae and Neisseria meningitidis. Most
courses of treatment involve the administration of antibiotics,
however this can obscure results from culture based methods,
therefore making a positive diagnosis diﬃcult. It is imperative
that the correct pathogen is identied to allow for the most
eﬀective course of treatment. Results obtained from this new
assay format are not aﬀected by the presence of any antibiotics.
SERS is a promising technique for the detection of bacterial
meningitis pathogens. SERS has previously been used to detect
DNA due to the high discrimination achieved from the molec-
ularly specic ngerprint spectra.17–19 Whilst SERS of individualThis journal is © The Royal Society of Chemistry 2014
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View Article OnlineDNA bases can be obtained, this does not allow identication of
the order of bases and therefore is not sequence specic. As a
result dye labels can be used to allow sequence specic detec-
tion of DNA using SERS.9Using a label, such as a uorescent dye
attached to a specic sequence, the SERS signal of the label will
be indicative of the presence of that specic sequence. SERS has
been employed in various multiplex assays for the detection of
several DNA sequences simultaneously. In 2002, Graham et al.
were the rst to use a SERS multiplex system for the detection of
the cystic brosis trans-membrane conductance regulator
(CFTCT) gene, which can be expressed in three forms.6 Further
developments include an assay that reported the multiplex
detection of DNA sequences coding for methicillin-resistant
Staphylococcus aureus (MRSA).18 The assay was used for the
detection of three genes associated with MRSA using three
diﬀerent uorophores as the SERS labels. Vo-Dinh et al. devel-
oped a multiplex DNA detection assay using “molecular senti-
nels”, a structure that contains a looped sequence of DNA held
together by two complementary sequences forming stems.20
“Molecular sentinels” have been used to achieve multiplexed
detection of two genes that are biomarkers for breast cancer.
These examples highlight the use of SERS for clinically
relevant targets however one of the main strengths of SERS is
the ability to detect several analytes in a mixture and without
separation steps. The simultaneous detection of ve labelled
oligonucleotides was reported by Faulds et al.4 Two diﬀerent
excitation wavelengths were used based on the responses the
diﬀerent dyes gave at diﬀerent wavelengths. Five labelled
oligonucleotides were mixed within a single sample and each of
the dyes was successfully detected at either of the twoFig. 1 Schematic of the SERS detection assay illustrating each step involv
and 50-phosphate modiﬁed probe that also possess a 30 ﬂuorophore mo
known as sandwich hybridisation (i), using 0.3 M phosphate buﬀered sali
magnetic beads (d) are then added to the reaction mixture (ii) and the n
ﬁcation. Subsequent washing steps (iii) take place to remove any exc
resuspended in 30 mL of exonuclease buﬀer (New England Biolabs, Herts,
stranded digestion to occur (iv) for 90 min at 37 C. The digestion produc
and spermine hydrochloride (20 mL, 0.1 M) (v) and SERS analysis is carrie
This journal is © The Royal Society of Chemistry 2014wavelengths, without the need for any multivariate analysis.
Following this success a 6-plex detection system was developed
using one excitation wavelength and this time employed che-
mometrics,5 which is becoming increasingly popular for the
analysis of Raman data.21,22 Each of the six dye labelled DNA
sequences in the mixture were successfully identied using
multivariate analysis. Zhong et al. then used the same 6-plex
mixture and analysed the results using Bayesian methods,
which gave a more accurate analysis of the various components
within the mixture.23
The assay format reported in this study involves the use of
the enzyme l-exonuclease (Fig. 1).57 It is a processive enzyme24–26
that digests one strand of 50-phosphorylated double stranded
DNA producing mononucleotides and leaving one DNA strand
intact.27 The enzyme has a toroidal structure with three
subunits. A central channel passes through the enzyme that
decreases in size from 30 A˚ to 15 A˚. Due to this feature, double
stranded DNA can only enter the wider end of the channel and
single stranded DNA is expelled from the narrow end.28 Only
one of the three subunits is bound to the DNA substrate, the
other two are present to ensure the enzyme moves in a proc-
essive manner along the full length of the DNA sequence and
does not move backwards. When digestion occurs, a positively
charged pocket within the subunit attracts the negatively
charged phosphorylated DNA strand. The phosphodiester
linkages are cleaved producing mononucleotides that leave
through the narrow end of the central channel.29 l-Exonuclease
has previously been used in aptamer research30 and has been
subject to many investigations into the kinetics and activity of
the enzyme under diﬀerent experimental conditions.31–34 Theed. Two selectively modiﬁed DNA sequences; 30 biotinylated probe (b)
diﬁcation (c) hybridise to a single target DNA sequence (a) in a process
ne (PBS) at 90 C for 10 min then 10 C for 10 min. Streptavidin coated
ewly formed duplex is retained on the beads due to the biotin modi-
ess/unhybridised DNA from the reaction mixture and the beads are
UK). l-Exonuclease (e) is then added to the reactionmixture for double
ts are then added to a solution containing silver nanoparticles (150 mL)
d out (vi) using an excitation wavelength of 532 nm and a diode laser.
Chem. Sci., 2014, 5, 1030–1040 | 1031
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View Article Onlineuse of l-exonuclease in this assay has the potential to exploit the
signal amplication compared to target amplication methods
such as PCR.35,36 The single strand of DNA that is le intact post-
digestion is capable of undergoing successive digestion cycles,
releasing the uorescent dye into solution and amplifying the
signal obtained.37
Here we report the combination of a new disease specic DNA-
based SERS assay that demonstrates the simultaneous detection
of three bacterial meningitis pathogens.38 Limits of detection that
rival current uorescent-based methods were obtained, however
more importantly, by using chemometric analysis, each pathogen
in the multiplex was successfully quantied.
Materials and methods
Colloid synthesis
Silver nanoparticles were synthesised using a modied Lee and
Meisel method.39 Silver nitrate (90 mg) was dissolved in 500 mL
distilled water. The solution was heated rapidly to boiling with
continuous stirring. Once boiling, an aqueous solution of
sodium citrate (1%, 10 mL) was added quickly. The heat was
reduced and the solution was le to boil gently for 90 min with
stirring. The colloid was then analysed by UV-vis spectroscopy
and the lmax was 411 nmwith the full width half-height (FWHH)
measured to be 103 nm. The concentration of the colloid was
calculated to be 0.3 nM.
Oligonucleotides
The three target pathogen sequences were those used by Guiver
et al. for their simultaneous detection using real-time PCR.38 Bio-
tinylated DNA and unmodied target DNA sequences were
purchased on a 0.01 mM scale with HPLC purication from Euro-
ns MWG (Ebersberg, Germany). 50-Phosphate/dye modied DNA
sequences were ordered on a 100 nM scale with HPLC purication
from Integrated DNA Technologies (Leuven, Belgium) (Table 1).
Buﬀer
Exonuclease buﬀer was supplied by New England Biolabs
(Cambridge, UK) consisting of; 67 mM glycine–KOH, 2.5 mM
MgCl2 and 50 mg mL
1 bovine serum albumin (BSA). The pH of
the buﬀer was 9.4. Exonuclease buﬀer was supplied at 10
concentration and was diluted to 1 concentration when used
in the assay.Table 1 Oligonucleotide sequences and modiﬁcations used in the SERS
Name Sequence (50–30)
Streptococcus pneumoniae TTCGAGTGTTGCTTAT
Streptococcus pneumoniae “Capture Probe” GCAACACTCGAA
Streptococcus pneumoniae “Reporter Probe” TGGCGCCCATAA
Haemophilus inuenzae CCACGCTCATTCGTTT
Haemophilus inuenzae “Capture Probe” AACGAATGAGCGTGG
Haemophilus inuenzae “Reporter Probe” CACCACTCATCA
Neisseria meningitidis ATGTGCAGCTGACACG
Neisseria meningitidis “Capture Probe” TCAGCTGCACAT
Neisseria meningitidis “Reporter Probe” CATTGCCACGTG
1032 | Chem. Sci., 2014, 5, 1030–1040PCR
PCR was carried out using a Stratagene MX3005P uorimeter
and the commercially available Qiagen PCR reagents. Each
reaction had a total volume of 25 mL; 2.5 mL of Qiagen reaction
buﬀer (10), 1 mL of MgCl2 solution (25 mM), 0.4 mL of deoxy-
nucleoside triphosphates (10 mM), 1 mL of forward primer
(10 mM), 1 mL of reverse primer (10 mM), 0.5 mL of Taq poly-
merase (5 U), 1 mL of template DNA (approx. 5  106 copies per
mL) and made up to the total volume (25 mL) with DEPC
(diethylpyrocarbonate) treated water. PCR was then carried out
using the following thermal prole: 10 min at 95 C, followed by
45 cycles of 95 C for 30 s, 58 C for 1 min then 72 C for 1 min
and a nal extension for 1 min at 72 C.Detection assay
A biotinylated modied sequence and a 50-phosphate/uo-
rophore modied sequence underwent a sandwich hybrid-
isation event with one complementary (target) sequence using a
Minicycler PTC-150 system. An aliquot of each DNA sequence
(10 mL, 1 mM) was added to a PCR tube containing phosphate
buﬀered solution (70 mL, 0.3 M). The temperature was held at
90 C for 10 min, and then was lowered to 10 C for 10 min. For
the no target control, the target DNA sequence was omitted and
replaced with distilled water, and the non-complementary
control used a sequence that was not complementary to either
of the modied probes in place of the target sequence. Once the
sequences were hybridised, 15 mL of streptavidin coated
magnetic beads were added to the PCR tubes and le at room
temperature for 30 min. Three washing steps were carried out
using phosphate buﬀered solution (70 mL, 0.3 M). The beads
were then resuspended in exonuclease buﬀer (30 mL, 1) and
lambda exonuclease was added (2 mL, 1 U) for digestion to occur
for 90 min at 37 C. SERS analysis was performed post-
digestion.SERS analysis
For the limit of detection studies and multiplex assay experi-
ments, SERS was carried out using an Avalon Instrument
Ramanstation R3 (Belfast, UK), with an excitation wavelength of
532 nm from a diode laser. Disposable 1.5 mL PMMA semi-
micro cuvettes were used. To the cuvette, 30 mL of l-exonuclease
digestion products was added to spermine hydrochloridedetection assay
50 Modications 30 Modications
GGGCGCCA — —
— Biotin
Phosphate Spacer18-10A-TAMRA
GATGAGTGGTG — —
— Biotin
Phosphate Spacer18-10A-Cy3
TGGCAATG — —
— Biotin
Phosphate Spacer18-10A-FAM
This journal is © The Royal Society of Chemistry 2014
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View Article Online(20 mL, 0.1 M), 250 mL distilled water and 150 mL silver citrate
colloid. The sample was then mixed thoroughly and immedi-
ately analysed by SERS. Spectra were baseline corrected using a
multipoint polynomial t and level and zero mode in Grams
soware (AI 7.00). When carrying out limit of detection studies,
5 scans of 5 replicate samples at each concentration were ana-
lysed. The equation of the line obtained from the dilution
studies was used to calculate the limits of detection. The limit of
detection was calculated to be 3 times the standard deviation of
the blank, divided by the gradient of the straight line. For the
chemometric studies, SERS analysis was performed using an
Avalon Plate Reader, with an excitation wavelength of 532 nm. A
96 well plate was placed onto a stage and the instrument's
soware was used to move the stage automatically so that a
spectrum can be recorded from each well. The accumulation
time was 0.01 s and each well was scanned 5 times. A single well
can hold 300 mL. Each well contained 30 mL of dye-labelled
oligonucleotide mixture (or post-assay mixture when testing the
model), 20 mL spermine tetrahydrochloride, 100 mL distilled
water and 150 mL silver citrate colloid. To train the PLS
prediction model a suitable and reduced number of base line
experiments (66 in total) were designed to be performed in the
lab. The design of such experiments was based on the theory of
Design of Experiments as previously described by Mabbott
et al.40 Five scans of ve replicates of each of the 66 diﬀerent dye
ratios were analysed and the spectra were averaged prior to
model construction. Following this additional samples were
generated to test the model and included: (i) additional dye-
labelled oligonucleotide combinations and (ii) samples aer
having gone through the complete SERS assay; the latter were
included as these are the closest to the clinical scenario.Chemometrics
Data were baseline corrected using the asymmetrical least
squared smoothing method.41 Principal component analysis
(PCA) was performed to assess the reproducibility of the data set
using Matlab soware version R2012a (The MathWorks, Natick,
MA, USA). PCA reduces the dimensionality of the SERS data,
making it easier to identify any variations in the spectra.42,43 PCA
was carried out on four diﬀerent data sets, three consisting of
spectra obtained from single pathogen detection experiments
and one data set obtained for the multiplex detection of the
three pathogens. For quantication of the three pathogens in
tertiary mixtures the supervised learning method of partial least
squares (PLS) regression was employed. PLS is a multivariate
calibration method that relates a set of independent variables X
(Raman intensities) to a set of dependent variables Y (dye-
labelled oligonucleotide concentrations). PLS projects the X and
Y variables into sets of orthogonal latent variables, scores of X
and scores of Y, so that the covariance between these two sets of
latent variables is maximized.44 The purpose of PLS is to build a
linear model Y ¼ XB + E, where B is a matrix of regression
coeﬃcients and E represents the diﬀerence (error) between
observed and predicted Y values.45 Aer calibration of the PLS
models, validation data (new Raman spectra) not used in model
building were used to challenge PLS. These included additionalThis journal is © The Royal Society of Chemistry 2014dye-labelled oligonucleotide combinations as well as samples
that had gone through the whole SERS assay. If these predic-
tions were correct then this would show that our approach
could successfully and simultaneously quantify the three
pathogens of bacterial meningitis. The PLS algorithm was run
in Matlab version R2012a and the scripts are available from the
authors on request.
Results and discussion
The bacterial pathogens Neisseria meningitidis, Streptococcus
pneumoniae and Haemophilus inuenzae are the most common
causes of acute bacterial meningitis, which is an extremely
serious and in most cases fatal infection that aﬀects the central
nervous system.46,47 Traditional laboratory methods involve
lengthy culture for the identication of bacterial meningitis
pathogens, which can take up to 36 hours.48,49 It has also been
reported that the administration of antibiotics prior to sample
collection has a detrimental eﬀect on the positive identication
of the bacterial meningitis pathogens. Moreover, several studies
have revealed that there is a marked discrepancy between the
number of suspected cases of bacterial meningitis and
conrmed cases of bacterial meningitis using culture
methods.38,50,51 A solution to this problem was to use a non-
culture method such as PCR, and this is now being used
extensively and involves the amplication of pathogen DNA
sequences and provides a universal detection technique for
bacteria.52However, this approach has been hindered due to the
presence of residual bacterial DNA that aﬀects any positive
results for identication of the pathogens. The most eﬀective
course of patient treatment is determined by the results
obtained from pathogen identication; therefore an ideal
method of identication must be eﬃcient in producing con-
rmative and more importantly reliable objective results. The
novel detection assay described herein provides an ideal alter-
native to traditional laboratory methods, eliminating the use of
DNA amplication and results obtained are not obscured by the
administration of antibiotics prior to sample collection. Initial
studies involved detecting one pathogen at a time using a SERS-
based assay and determining the sensitivity of each pathogen
target. Following these experiments, a triplex was designed to
detect the three pathogens, N. meningitidis, S. pneumoniae and
H. inuenzae simultaneously, all of which are causes of bacterial
meningitis. Chemometric analysis was then performed to
quantify each pathogen in the multiplex aer the detection
assay was performed.
Fig. 1 illustrates the multi-step process used for the detec-
tion of the bacterial meningitis pathogens. First, the synthetic
pathogen sequence was hybridised to its two respective
complementary modied synthetic DNA sequences. Streptavi-
din coated magnetic beads were then added, which retained
only fully formed duplex DNA. With subsequent washing steps,
any unhybridised or excess DNA was removed from the assay.
l-Exonuclease was then added and digestion of the 50-phos-
phate modied probe that also possessed a uorescent dye
took place, which therefore liberated the dye from the duplex
that was attached to streptavidin coated magnetic bead. TheChem. Sci., 2014, 5, 1030–1040 | 1033
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View Article Onlineproducts of digestion were then added to a mixture of silver
nanoparticles (capped with the citrate during reduction) and
spermine hydrochloride; this was then followed by SERS
analysis, which generated the characteristic SERS spectra of
the uorescent dye present on the “Reporter” probe. Citrate
reduced silver nanoparticles have an overall negative charge on
the metal surface, which repels the negatively charged phos-
phate backbone of DNA.53,54 The aggregating agent spermine
hydrochloride is positively charged and is used to reduce the
negative charge on the nanoparticle surface, allowing the DNA
to come into close proximity with the metal surface.55 For SERS
enhancement to be obtained the DNA must be either adsorbed
or very close to the metal surface and using spermine hydro-
chloride facilitates the DNA to come in close proximity to the
silver surface.56 As well as reducing the negative surface charge,
spermine hydrochloride encourages the formation ofFig. 2 SERS spectra obtained from single pathogen detection using th
S. pneumoniae; (b) SERS peak intensities at 1650 cm1 for assay and bo
observed when detecting N. meningitidis; (d) SERS peak intensities at 64
SERS spectra of Cy3 observedwhen detectingH. inﬂuenzae; (f) SERS peak
inﬂuenza. SERS spectra were recorded using an excitation wavelength o
5 replicate samples 3 times with an accumulation time of 1 s. Averages
1034 | Chem. Sci., 2014, 5, 1030–1040nanoparticle clusters, which create “hotspots” such that when
a laser is applied an enhancement in the unique vibrational
spectrum is obtained.3 Along with the detection of single
bacterial meningitis pathogens, two control experiments were
undertaken each time the assay was performed, no target and
non-complementary. The non-complementary control was
diﬀerent for each pathogen detection assay. When detecting
S. pneumoniae pathogen, the synthetic sequence for N. menin-
gitidis was present and treated as the non-complementary
control. The H. inuenzae sequence was the control when
detecting N. meningitidis and for the detection of H. inuenzae,
the synthetic sequence coding for S. pneumoniae was the non-
complementary control. No SERS peaks from the uorescent
dye labels should have been observed in either control as the
synthetic pathogen target sequence is not present in the assay
and therefore the dye labelled probe will be removed duringe SERS assay: (a) SERS spectra of TAMRA observed when detection
th controls when detecting S. pneumoniae; (c) SERS spectra of FAM
6 cm1 for assay and both controls when detecting N. meningitidis; (e)
intensities at 1586 cm1 for assay and both controls when detectingH.
f 532 nm and a diode laser. Peak intensities were obtained by scanning
are shown and error bars are  one standard deviation.
This journal is © The Royal Society of Chemistry 2014
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View Article Onlinethe washing steps that were carried out prior to enzyme
digestion.
Exact complement synthetic DNA sequences were used for
the single pathogen detection experiments. Each synthetic
pathogen target sequence had two complementary synthetic
probe sequences, each complementary to half of the target
sequence. One sequence wasmodied with a biotin group at the
30 end of the strand and this was known as the “Capture” probe.
The other sequence, referred to as the “Reporter” probe, was
modied at the 50 end with a phosphate group that is needed for
enzyme digestion to occur; at the 30 end there was a spacer-18,
which is an 18-atom hexa-ethyleneglycol spacer that was used to
stop digestion resulting in a sequence of 10 adenine bases and
the uorescent dye being le on the 30 end that would then be
free for SERS detection. The 10 adenine bases remained
attached to the uorescent dye post-digestion and previous
studies have shown that this adenine “tail” enhances the SERS
signal compared to free dye that does not have a DNA “tail”.11,57
For each of the three pathogens a diﬀerent uorescent dye was
used to label each of the three target specic probes; when
detecting S. pneumoniae the uorescent dye TAMRA was present
on the “Reporter” probe, for the detection of N. meningitidis
FAM was the uorescent dye monitored and nally for the
detection of H. inuenzae Cy3 was the chosen dye.
The synthetic DNA sequence representative of S. pneumoniae
was successfully detected using the SERS assay. This was carriedFig. 3 The assay was performed for each pathogen using the speciﬁed
heights for each pathogen are shown: (a) 1650 cm1 peak height used to
height used to calculate the limit of detection for N. meningitidis; (c) 1
inﬂuenzae. Table (d) summarises calculated limits of detection. SERS spe
an excitation wavelength of 532 nm and a diode laser power of 100mW. E
Error bars are  one standard deviation.
This journal is © The Royal Society of Chemistry 2014out by monitoring the characteristic TAMRA peaks in the SERS
spectrum (Fig. 2a), as this was the dye modication on this
“Reporter” probe. A prominent peak was observed at 1650 cm1
that was present due to the C]C bonds in the dye structure and
the peaks observed around 1500–1560 cm1 represented the
aromatic ring vibrations.58 All peaks observed in the spectrum
were attributed to the structure of TAMRA. As predicted the no
target and non-complementary controls showed no SERS signal
since the pathogen sequence had been omitted from the assay,
therefore a fully formed duplex was not obtained, i.e. the
“Reporter” probe was not present to facilitate SERS detection
(Fig. 2b). N. meningitidis was detected successfully, using the
respective synthetic DNA sequence, by monitoring the charac-
teristic FAM peaks in the SERS spectrum as this was the dye
present on the “Reporter” (Fig. 2c). The peak at 1625 cm1 was a
result of the C]C vibrations, and similar to the SERS spectrum
of TAMRA, peaks within the range 1400–1500 cm1 represented
CH2 and CH3 vibrations.58 Peaks between 1500 and 1600 cm
1
were from the aromatic rings within the structure of FAM. Again
no target and non-complementary controls did not produce any
SERS peaks as expected since the pathogen sequence was not
present in the assay and further analysis of peak intensities at
648 cm1 demonstrated that both controls showed no SERS
intensity at this specic characteristic FAM peak (Fig. 2d).
Finally, the synthetic DNA sequence of H. inuenzae was also
detected successfully using the novel SERS assay by monitoringconcentration range. The calibration curves of normalised SERS peak
calculate the limit of detection for S. pneumoniae; (b) 646 cm1 peak
586 cm1 peak height used to calculate the limit of detection for H.
ctra were recorded using an Avalon Instrument Ramanstation R3, with
ach point represents the average of 5 replicates of each concentration.
Chem. Sci., 2014, 5, 1030–1040 | 1035
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View Article Onlinethe characteristic SERS peaks of the dye Cy3, which was
chemically attached to this probe (Fig. 2e). Aromatic vibrations
were observed between 1500 cm1 and 1600 cm1. The intense
peak observed at 1200 cm1 was due to the aliphatic chain in
the dye structure.58 The non-complementary control gave no
SERS intensity as expected, as the synthetic pathogen sequence
was excluded from the assay. This was reaﬃrmed upon further
analysis of the peak at 1586 cm1. However, upon peak analysis
for the no target control there was a small amount of SERS
intensity observed. This can be attributed by the presence of a
larger background in the SERS spectrum for this control
compared to the non-complementary control and as it was the
absolute intensity values used to calculate the peak heights,
negligible SERS intensity could be observed (Fig. 2f). To
summarise, when synthetic pathogen DNA was omitted or a
non-complementary sequence was present in the assay, no
SERS signal was obtained, therefore demonstrating the excel-
lent robustness and strength of this assay for diagnostic
purposes in clinical use.
Once it was ascertained that a signicant enhancement was
observed in the presence of each of the chosen pathogens, a
dilution series was carried out to determine the lowest concen-
tration of synthetic pathogen DNA that could be detected using
the assay. An initial concentration range of 6  108 M to 1 
109 M of synthetic pathogen DNA was used throughout the
SERS assay and for each study the limits of detection were
determined using the equation of the line obtained from the
dilution studies and calculating the limit of detection to be 3
times the standard deviation of the blank, divided by the
gradient of the straight line (Fig. 3). The data were normalisedFig. 4 Stacked SERS spectra showing the spectra obtained from the simu
detection assay (a) and the SERS spectra obtained from the detectio
concentration of 1.13  105 copies per mL (b), H. inﬂuenzae using PCR pro
using PCR product concentration of 2.4  104 copies per mL (d). SERS sp
diode laser with a 10 s accumulation time. The red dotted lines show pe
1036 | Chem. Sci., 2014, 5, 1030–1040using the intensity of the standard. This SERS assay has previ-
ously been used successfully for the detection of Chlamydia tra-
chomatis with a reported detection limit of 77 pM.57 The
calculated limits of detection for the synthetic DNA of each of the
three pathogens, N. meningitidis, S. pneumoniae and H. inuen-
zae, were 45.3 pM, 99.5 pM and 21.7 pM respectively. The
detection limits obtained from this work are within the range of
the limit obtained from previous work, which illustrates the
robustness of this assay in that it can be applied to various
classes of diseases and yield similar and successful results.
Furthermore, with low detection limits in the pico-molar range it
is a highly desirable detection method in clinical diagnostics
where concentrations of disease DNA under analysis are very low
and currently very diﬃcult to measure using uorescence.
Indeed we have reported several times signicantly lower detec-
tion limits of SERS compared to uorescence of the same dye.3
The SERS spectra of FAM and TAMRA are similar which is
due to similarities in their chemical structures. By contrast, Cy3
has a markedly diﬀerent SERS spectrum due to the diﬀerence in
chemical structure compared to the other two dyes. FAM and
TAMRA are xanthene based dyes compared to Cy3, which is an
indole based cyanine. Despite the similarity in the SERS spectra
of FAM and TAMRA, they can be used successfully in amultiplex
system along with Cy3. Multiplex studies were carried out using
both synthetic target pathogen DNA and PCR product, gener-
ated from the amplication of template sequences of each
pathogen. Exact complement of synthetic DNA of each path-
ogen was used as initial proof-of-concept that the multiplexed
SERS detection assay will work for these specic bacterial
meningitis pathogens, this proved to be successful. Therefore,ltaneous detection of all three bacterial meningitis pathogens using the
n of each pathogen separately; N. meningitidis using PCR product
duct concentration of 7.24  105 copies per mL (c) and S. pneumoniae
ectra were recorded using an excitation wavelength of 532 nm and a
aks that are unique to each SERS spectrum and hence each pathogen.
This journal is © The Royal Society of Chemistry 2014
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View Article OnlinePCR product was then used to establish that the multiplexed
assay could be used to analyse clinically relevant CSF samples.
For this novel assay to be biologically relevant, it must perform
well using PCR product of the pathogens. The assay was used in
amultiplex scenario where PCR products of each pathogen were
to be detected simultaneously. In the reaction mixture there
were nine DNA sequences in total; three pathogen PCR product
sequences, three complementary “Capture” probes and three
complementary “Reporter” probes. Each step of the SERS
detection assay was carried out in an identical fashion for single
pathogen detection. As can be seen in Fig. 4, there is at least one
identiable peak of each dye associated with each of the three
pathogens readily observed.
The multiplex spectra obtained are multivariate in nature,
therefore it is diﬃcult to analyse the spectra by eye alone. To
overcome this, multivariate analysis in the form of principal
component analysis (PCA) was performed on the multiplex
SERS spectrum, as well as the three separate dye-labelled
oligonucleotide SERS spectra, associated with the pathogens.
PCA is an excellent approach to reduce the dimensionality of
the SERS data.42 The resulting principal component (PC) scores
plot (Fig. 5) clearly illustrates how strong the relationship was
between the multiplex spectra and the pathogen spectra. As can
be seen in Fig. 5, the dye-labelled oligonucleotide SERS spectra
form the edges of a triangle. Five scans of the 5 replicate
samples are shown in the PCA plot and each group is tightly
clustered illustrating the excellent reproducibility of the SERS
spectra. The SERS spectra from the multiplex sample are alsoFig. 5 PCA scores plot showing the relationship between themultiplex sp
the 5 replicates were recorded using an excitation wavelength of 532 nm
cluster are the N. meningitis spectra, green cluster is the H. inﬂuenzae s
This journal is © The Royal Society of Chemistry 2014clustered tightly together and are clearly separated and found
towards the middle of all three dye-labelled oligonucleotide
clusters. It is noteworthy that the multiplex cluster which
contains a 1 : 1 : 1 mixture of all three probes is positioned close
to the N. meningitidis cluster, which suggests that it has stronger
FAM signal compared to the other two dye-labelled oligonu-
cleotides. This means that more powerful supervised learning
method will be needed to eﬀect accurate quantication of the
three probes and hence the three bacteria in tertiary mixtures.
The crucial aspect of this work was that, based on the
knowledge that all three pathogens are present in the multiplex,
we wanted to determine the amount of each pathogen present
within tertiary mixtures. This was performed by quantifying the
three dye-labelled oligonucleotides present which will be
expected to be proportional to the amount of target pathogen
present in the assay. In order to quantify the dye-labelled
oligonucleotides in the multiplex, fractional factorial design
was used to determine the lowest number of experiments that
test an equal combination of low, median and high levels for all
3 factors (dye-labelled oligonucleotides). This was calculated to
be 66 diﬀerent dye ratios. These were analysed by SERS. For ease
of visualisation each set of replicates were averaged to provide
66 SERS spectra prior to PCA. This resulted in the generation of
a single PCA scores plot that shows the quantitative relationship
of each of the dye-labelled oligonucelotides within the 66
tertiary mixes. In Fig. 6a–c three PCA plots are produced which
have identical PC scores locations. The size of the dot is
proportional to the concentration of the dye-labelledectra and each of the three single pathogen spectra. 5 Scans of each of
and a diode laser. The blue cluster contains the multiplex spectra, red
pectra and the purple cluster are the S. pneumoniae spectra.
Chem. Sci., 2014, 5, 1030–1040 | 1037
Fig. 6 (a–c) PCA score plots for each dye-labelled oligonucleotide using averaged replicates of the 66 data points. (d–f) PLS regression models
for each dye-labelled oligonucleotide generated using the same 66 average data points. The black dots were used to build themodel and the red
dots were used to test the linearity of the model. Results show that quantiﬁcation of each dye is clearly possible.
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View Article Onlineoligonucleotide present in the mixture. The triangular shapes of
the score plots are a very good indication that each dye-labelled
oligonucleotide present can be quantied. Using these 66 data
points, PLS regression models were constructed (Fig. 6d–f). The
data points were spilt into two groups: one used to build the PLS
model (black) and one used to test the model (red). The three
PLS models all show an expected linear relationship (that is to
say they fall on the expected y ¼ x line), which further indicates
excellent reproducibility and more importantly that the dyes
can be quantied in a multiplex.
The model was originally built using only dye-labelled
oligonucleotide mixtures; that is to say the detection assay wasTable 2 Comparison of the results obtained from the predictions
using the model and the actual dye-labelled oligonucleotide
concentrations present
Real dye % Predicted dye %
FAM TAMRA Cy3 FAM TAMRA Cy3
1 0 0 6.67 0 0 5.53
2 0 0 33.3 0 0 24.7
3 0 6.67 0 0 8.13 0
4 0 6.67 33.3 0 6.27 31.1
5 0 20 20 0 20 17.5
6 0 33.3 6.67 0 25.2 5.73
7 0 33.3 33. 3 0 32 30.2
8 6.67 0 0 5.33 0.2 0.07
9 6.67 0 33. 3 5.8 0 31.1
10 6.67 6.67 6.67 6.2 7.07 6.27
11 6.67 6.67 33.3 6.27 5.8 29.7
12 6.67 20 20 4.07 14.9 16.4
13 6.67 33. 3 0 6.27 25.4 0
14 6.67 33.3 20 4.93 28 18.8
15 6.67 33.3 33.3 6.13 29.9 26.7
1038 | Chem. Sci., 2014, 5, 1030–1040not performed in full. A second model was then generated that
was scaled to quantify the dye-labelled oligonucleotides in the
amounts that would be present in a sample post-assay. The re-
scaledmodel was tested using “blind” samples, where the actual
dye-labelled oligonucleotide concentrations were unknown to
the analyst but not to the PLS model. The predicted results were
compared to the actual values and a selection of these are shown
in Table 2. Overall, the predicted results are in very good
agreement with the actual concentrations of dyes added. A
second batch of testing was performed where the samples used
were all post-assay samples; this was the most important testing
experiment as it mimicked a real clinical situation. Excitingly,
very good agreement was also obtained for post SERS assay
testing as can be seen in Table 3. The successful results obtained
from the testing of the model shows that each of the three dye-
labelled oligonucleotides can be quantied within the multiplex
aer the detection assay has been performed and regardless of
whether the other two dye-labelled oligonucleotides are present.
Error values were estimated for each dye-labelledTable 3 Predicted dye-labelled oligonucleotide percentages using
post assay samples used to further test the model
Real dye % Predicted dye %
FAM TAMRA Cy3 FAM TAMRA Cy3
1 6.67 6.67 6.67 7.67 7 6.2
2 6.67 6.67 0 6.4 6.87 0.07
3 6.67 0 6.67 5.87 0 5.93
4 0 6.67 6.67 0 7.27 6.4
5 6.67 0 0 6.47 0 0
6 0 6.67 0 0.8 7.53 2.07
7 0 0 6.67 3.27 0 8.07
8 0 0 0 0.07 0.07 0
This journal is © The Royal Society of Chemistry 2014
Fig. 7 Error estimation plots for each dye-labelled oligonucleotide. Overlap between actual values (green) and predicted values (red) shows the
closeness of the two values and therefore the normalised root-mean-square error (NRMSE) associated with the predictions.
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View Article Onlineoligonucleotide (Fig. 7) and the overlap between the actual and
predicted values is excellent and indeed reects a small error
associated with the predictions obtained from the PLS model.
This emphasises the accuracy and reliability of the chemometric
model built to quantify the three target pathogens. Not only can
the detection assay be used to detect three bacterial meningitis
pathogens simultaneously, but each pathogen can be success-
fully quantied in the multiplex using chemometrics.
Conclusions
A SERS assay has been successfully applied to the detection of
three bacterial meningitis pathogens: Neisseria meningitidis,
Streptococcus pneumoniae andHaemophilus inuenzae. The assay
detected all three pathogens simultaneously producing consis-
tent and accurate results. More importantly, using chemo-
metrics, each target pathogen could be quantied, post-assay,
in the multiplex, which is extremely desirable in clinical diag-
nostics. This is the rst time that a multiplex SERS assay has
been carried out where each component (dye-labelled oligonu-
cleotide) was successfully identied and quantied within the
multiplex. This method of bacterial meningitis detection
produces consistent results faster than conventional culture
based methods. We believe this is a promising alternative to
current PCR methods of detection and could be applied to the
detection of a variety of bacterial, fungal and viral diseases.
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